Form 4 Tracker
Hannah Valantine

Director · 6 filings · Latest: Jul 16, 2026

BridgeBio Pharma, Inc.
CareDx, Inc.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BBIO
ERICKA VON KAEPPLER & DENIS VON KAEPPLER JT TEN—Jun 26, 2025
Proposed Sale
$44.13398$17.6K—
CDNA
HANNAH VALANTINE—Jun 18, 2025
Proposed Sale
$19.5210,570$206.3K—
BBIO
HANNAH A VALANTINE—Jun 10, 2025
Proposed Sale
$40.004,292$171.7K—
BBIO
HANNAH A VALANTINE—Mar 6, 2025
Proposed Sale
$32.5812,875$419.5K—

← Previous

Page 2 of 2